Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex
about
HIV-1 induced bystander apoptosisThe viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestorPeptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion IntermediateDesign of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to ResistanceAtomic structure of a thermostable subdomain of HIV-1 gp41Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display librariesSensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptorInhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanismStructural optimization and de novo design of dengue virus entry inhibitory peptidesThe ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptideSpecific single or double proline substitutions in the "spring-loaded" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion activity.Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replicationBiophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1. Implications on viral fusion mechanism.Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41.The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.The Membrane-Proximal Region of C-C Chemokine Receptor Type 5 Participates in the Infection of HIV-1.Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein.Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion.A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usageMutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein.Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.Activity of the Mason-Pfizer monkey virus fusion protein is modulated by single amino acids in the cytoplasmic tail.Caveolin-1 modulates HIV-1 envelope-induced bystander apoptosis through gp41.Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domainsHIV infection upregulates caveolin 1 expression to restrict virus production.Morphological changes and fusogenic activity of influenza virus hemagglutinin.Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilizationCovalent fusion inhibitors targeting HIV-1 gp41 deep pocket.Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediatesPeptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sitesEstablishing Restricted Expression of Caveolin-1 in HIV Infected Cells and Inhibition of Virus Replication.Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission.
P2860
Q22241221-B88D24B9-30F0-4C01-B597-859DD4725917Q24796207-25FB1E1E-61C3-4712-A674-F9BB0059A2D4Q27491339-B3B25BCA-9D18-41BB-991B-DF5988802F12Q27664086-6F2AE2CF-F7F8-42B6-A132-12680632D84CQ27746904-B945F4C9-206B-4941-9E92-A505C5F23F03Q28343374-5D49DFD5-60A9-4657-825E-92D14E2EA1D8Q28346124-2C9A54FD-061A-49D0-A905-E6718D2EA34DQ28379257-04A44C5A-39AA-497F-91B5-0906B4911E10Q28474595-40C84B07-181E-4766-ACBD-6597991D0A77Q28646857-75B4FD13-E837-4067-A800-77ED8B749FA7Q30442103-D6D3783D-EB2D-436A-97FA-98470AB6DAC8Q30453537-54D1096B-C1E2-4C32-9E10-5C174BEBF639Q30558462-9E24A805-8B45-4C77-B90B-872D2F33C011Q30706865-C99FC54E-DDB4-4CD2-930E-D02DCCA89841Q30846393-FEB176A2-722B-4609-AB35-E04CA954B903Q33269255-1AAD0030-A476-4518-ADAA-1C1778E4AE89Q33595068-BD94909C-AB06-4E54-B785-8AF565BC712BQ33646121-D94F6842-20B5-4F3F-BAD5-995DC872E913Q33648376-4F78CAF5-0AAD-46CC-A8E8-747EC87358F0Q33654081-1567723F-2785-49AA-BCF5-5FFDF59B6E6AQ33782296-EC115D52-B5E9-4570-8B64-77055A4A0212Q33784040-F1F48263-1AC4-46C6-B3F5-C5D1AC94F80AQ33807129-C4C937D7-DD8F-407F-B15A-3F5A4FA3F7DDQ33814294-6C6C9FE8-8EFE-47E4-8CA5-400537FECEF6Q33815821-CD33BB40-2A07-4020-8C89-703AD88BF44AQ33943822-A73C89A0-04A8-4529-BDD6-86DC48942703Q33951142-49B76B8C-1D2F-486D-B57E-EDF312A7A624Q33987373-E196CD75-6E23-4DE8-9A93-D27BA725D03DQ33987377-C5E1C7EB-AF4C-45E0-BFB3-208999D93D13Q33990498-D35C0ECA-5694-477E-927F-8CA362960D88Q34045610-5478D095-0D79-4763-951B-37B2266400ADQ34120134-30BE55A0-C0DC-4090-818E-F2A34EFCBFFFQ34166993-C5AFFB74-4DB4-46BE-B1E6-0559C1B26302Q34184290-E7D75D72-4751-48E9-A953-748FE6F1A8ADQ34298481-38D40223-5EC5-4C2B-BDA0-1B41350BDEFBQ34341098-635B7D5D-DDE0-4839-8CAE-5A2721A9D6F3Q34466260-FCF031EB-A774-4F55-89C7-C30DF8309415Q34529676-0530A44D-6858-4915-BB15-F0EDCD47F6DBQ34761552-4F824D9D-70B9-4F62-9F84-E5CA605E35F6Q34899225-392230D7-5F38-491E-B713-C08717D64487
P2860
Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Propensity for a leucine zippe ...... ly of the glycoprotein complex
@ast
Propensity for a leucine zippe ...... ly of the glycoprotein complex
@en
type
label
Propensity for a leucine zippe ...... ly of the glycoprotein complex
@ast
Propensity for a leucine zippe ...... ly of the glycoprotein complex
@en
prefLabel
Propensity for a leucine zippe ...... ly of the glycoprotein complex
@ast
Propensity for a leucine zippe ...... ly of the glycoprotein complex
@en
P2093
P2860
P356
P1476
Propensity for a leucine zippe ...... ly of the glycoprotein complex
@en
P2093
T Greenwell
T Matthews
P2860
P304
12676-12680
P356
10.1073/PNAS.91.26.12676
P407
P577
1994-12-01T00:00:00Z